Prognostic value of circulating tumor DNA and copy-number alterations in patients receiving tandem [225Ac]Ac-/[177Lu]Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer: a prospective observational study

Mariam Amghar, Thomas Hielscher, Tobias Rausch, Hilal Özgür, Ulrike Bauder-Wüst, Hendrik Rathke, Frank Bruchertseifer, Alfred Morgenstern, Mareike Roscher, Vladimír Beneš, Clemens Kratochwil, Martina Benešová-Schäfer

Open source

DOI: 10.1186/s12885-026-16791-9
Published: 2026-08-29
Container: BMC Cancer
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12885-026-16791-9,
  title = {Prognostic value of circulating tumor DNA and copy-number alterations in patients receiving tandem [225Ac]Ac-/[177Lu]Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer: a prospective observational study},
  author = {Mariam Amghar and Thomas Hielscher and Tobias Rausch and Hilal Özgür and Ulrike Bauder-Wüst and Hendrik Rathke and Frank Bruchertseifer and Alfred Morgenstern and Mareike Roscher and Vladimír Beneš and Clemens Kratochwil and Martina Benešová-Schäfer},
  year = {2026},
  journal = {BMC Cancer},
  doi = {10.1186/s12885-026-16791-9},
  url = {https://doi.org/10.1186/s12885-026-16791-9}
}

RIS

TY  - JOUR
TI  - Prognostic value of circulating tumor DNA and copy-number alterations in patients receiving tandem [225Ac]Ac-/[177Lu]Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer: a prospective observational study
AU  - Mariam Amghar
AU  - Thomas Hielscher
AU  - Tobias Rausch
AU  - Hilal Özgür
AU  - Ulrike Bauder-Wüst
AU  - Hendrik Rathke
AU  - Frank Bruchertseifer
AU  - Alfred Morgenstern
AU  - Mareike Roscher
AU  - Vladimír Beneš
AU  - Clemens Kratochwil
AU  - Martina Benešová-Schäfer
PY  - 2026
JO  - BMC Cancer
DO  - 10.1186/s12885-026-16791-9
UR  - https://doi.org/10.1186/s12885-026-16791-9
ER  -

APA

Amghar, M., Hielscher, T., Rausch, T., Özgür, H., Bauder-Wüst, U., Rathke, H., Bruchertseifer, F., Morgenstern, A., Roscher, M., Beneš, V., Kratochwil, C., & Benešová-Schäfer, M. (2026). Prognostic value of circulating tumor DNA and copy-number alterations in patients receiving tandem [225Ac]Ac-/[177Lu]Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer: a prospective observational study. BMC Cancer. https://doi.org/10.1186/s12885-026-16791-9

Source records

crossref · retrieved 2026-09-26T06:35:13.533Z